ABSTRACT. Recombinant vaccinia virus (rVV) was constructed by inserting Rinderpest Virus (RPV) nucleocapsid (N) protein gene. The rVV expressed RPV-N protein in the rVV-infected cells. The rVV was shown to produce RPV-N-specific antibody in mice. -KEY WORDS: nucleocapsid protein, recombinant vaccinia virus, Rinderpest Virus.
were picked-up by hemadsorption assay with chicken erythrocytes [8] .
The expression of the N protein was examined by the Western blot using anti-RPV-N monoclonal antibody. Confluent RK13 cells were infected with the HA(-) clones or parental mO strain as a control. The cellular proteins were resolved by use of SDS-polyacrylamide gel electrophoresis, and electrotransferred to PVDF membrane (Millipore Corp.). After coating with 3% gelatin, the paper was reacted with mouse anti-RPV-N monoclonal antibody G11 [9] . Immunoreactive proteins were detected using peroxidase-conjugated anti-mouse antibodies. As shown in Fig. 1 , the rVV-infected cells produced a major protein band of approximately 60 kD which corresponds to RPV-N protein expressed in baculovirus (Autographa californica Rinderpest Virus (RPV) belongs to the morbillivirus subgroup of the family Paramyxoviridae, and causes acute fatal disease in cattle. Since sporadic outbreaks of rinderpest result in a serious damage to economy and ecology in Africa, the Middle East and South Asia, development of a heatstable vaccine is mandatory for RPV eradication in these tropical countries. In morbilliviruses, at least six viral proteins, the nucleocapsid (N) protein, the hemagglutinin (H) protein, the fusion (F) protein, the matrix (M) protein, the large (L) protein and the polymerase-associated (P) protein have been identified. Recombinant vaccinia virus expressing RPV-H or -F proteins have been shown to confer a protective immunity in rabbits and cattle [2, 3, 11, 14, 15] . On the other hand, the immunological significance of N protein and its contribution for protection against RPV are not clear. In the present study, we constructed a rVV expressing RPV-N protein of RPV and examined its immunogenicity in mice.
The donor plasmid containing the entire RPV-N gene and vaccinia virus hemagglutinin gene were constructed for homologous recombination. RPV-N gene from the lapinized Nakamura III (L) strain that had been previously cloned in Okayama-Berg cloning plasmid [10] was excised by XhoI and AflII. The AflII-XhoI DNA fragment was blunt-ended and inserted into the SmaI site of pVR1 harboring vaccinia virus hemagglutinin gene and a promoter of vaccinia virus early 7.5 kD protein gene [6] . The resultant vector inserting the N gene placed downstream of the 7.5 kD promoter was named pVR1-RPV-N.
To obtain the rVV containing the N gene, pVR1-RPV-N was transfected to rabbit kidney cells (RK13) infected with an attenuated vaccinia virus, LC16mO (mO) [5] by electroporation. Briefly, 15 µg plasmid and the infected cells (1 × 10 7 ) in 0.5 ml PBS were pulsed with 200V, 950 µF (BIO RAD), and co-cultured with confluent 5 × 10 6 RK13 cells. The hemagglutinin negative (HA (-)) clones nuclear polyhedrosis virus) vector system [7] . Several minor bands with smaller molecular weight were also detected in rVV-infected cells as well as baculovirus-infected ones probably due to the degradation of N protein by intracellular proteolysis. Any bands were not detected in the control cell lysates. The anti-RPV-N monoclonal antibody G11 reacted specifically with the plaques formed by the rVV on RK13 cells when stained by peroxidase-conjugated anti-mouse antibody, but not with those formed by the mO strain (data not shown).
BALB/c mice were inoculated with 1 × 10 8 p.f.u. of the rVV or mO, and examined for the production of antibody to the N protein by enzyme-linked immunosorbent assay (ELISA) as described previously [7] . Briefly, partially purified N protein expressed in baculovirus vector system was diluted to a final concentration of 3.5 µg/ml with carborate-bicarborate (50 mM, pH9.6) buffer (CBB). Two hundred µl of this solution was added into each well of microtiterplates. CBB containing 1% (w/v) gelatin was used to block nonspecific binding. After washing with PBS containing 0.05% Tween-20, 1/500-diluted mouse sera were incubated for one hour at 37°C. After washing, HRPconjugated goat anti-mouse IgG antibody was added. O-phenylenediamine solution was used as substrate, and optical density at 492 nm was measured. As shown in Table 1 , the development of RPV-N specific antibodies was observed in all the rVV-vaccinated mice from one week post vaccination. The antibody was not detected in the control mice vaccinated with the parental vaccinia virus mO strain.
In this study, we constructed the rVV expressing the N protein of RPV and showed its immunogenicity in mice as shown by anti-RPV-N antibodies. The significance of the N protein in protective immunity against RPV infection is not understood, although the N protein is considered to be important in inducing cell-mediated immunity for other virus system such as influenza or rabies viruses. For the morbilliviruses to which RPV belongs, rVVs expressing either the N protein of measles virus (MV) or that of canine distemper virus [1, 12] , and recombinant adenovirus expressing MV-N [4] have been reported to induce a cellmediated immunity and to protect mice against encephalitis induced by the intracerebral inoculations of neuro-adapted viruses. However, the protective role of the N protein against the systemic infection, which is the characteristics of natural infection with morbilliviruses, has not been reported due to the lack of suitable animal models for measles and canine distemper viruses. As RPV causes a marked systemic infection in both rabbit [5, 13] and cattle models, the rVV constructed in this study will serve as a useful tool for such studies.
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